Position in VCEL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$211,060
-$18,241 QoQ
Shares Held
4,744
-12.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#232
of 315 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NorthRock Partners, LLC holds $1,787,469 across 5 Biotechnology names. VCEL ranks #5 (11.8% of the industry book) .
All Filings in VCEL
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,060 | 4,744 | Shares | Sole | 2026-08-11 | |
| 2025-06-30 | $229,301 | 5,389 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $241,037 | 5,402 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $296,623 | 5,402 | Shares | Sole | 2025-04-22 | |
| 2024-09-30 | $227,938 | 5,395 | Shares | Sole | 2025-04-22 | |
| 2024-06-30 | $247,522 | 5,395 | Shares | Sole | 2025-04-22 | |
| 2024-03-31 | $280,335 | 5,389 | Shares | Sole | 2025-04-22 | |
| 2022-03-31 | $210,133 | 5,498 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $215,953 | 5,495 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $267,131 | 5,474 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $287,070 | 5,468 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $301,469 | 5,427 | Shares | Sole | 2021-05-11 | |
| No filing history on record for this holder in this stock. | ||||||